Hoag healthcare system in Orange County, CA, has launched a clinical trial to assess the prostate cancer PET imaging radiotracer Pylarify in patients newly diagnosed with intermediate disease.
“The MIRROR trial aims to bridge the gap in prostate cancer management by evaluating the utility of Pylarify imaging in favorable intermediate prostate cancer,” noted study lead Gary A. Ulaner, MD, PhD, of the Hoag Family Cancer Institute, in a news release.